Nuvation Bio (NYSE:NUVB) Q3 2026 Earnings Call
Nuvation Bio (NYSE:NUVB) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Nuvation Bio Inc. (NYSE:NUVB)
- Period
- Q3 2026 earnings call
- Date
- Wed, Nov 4, 2026, 4:30 PM ET
On 6ix: 6ix.com/event/nuvation-bio-inc-nuvb-q3-2026-earnings-call
Latest news releases
- NYSE:NUVB — Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026 · Wed, Oct 21, 2026
- NYSE:NUVB — Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI-Naïve Advanced ROS1-Positive Non-Small Cell Lung Cancer · Wed, Sep 16, 2026